Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia

Autor: Marilyn Stovall, Charles A. Sklar, Stella M. Davies, Barry D. Anderson, Jerry Finklestein, Stephen Qualman, Daniel C. Bowers, Gerald S. Gilchrist, Maura O'Leary, Julie Blatt, Gail E. Tomlinson, Lillian R. Meacham, Sue Hammond, Robert J. Hayashi, Jane Sande, Paul C. Nathan, Lorrie F. Odom, Robert E. Goldsby, Suwen Li, W. Anthony Smithson, George R. Buchanan, Kimberly Whelan, Lisa Diller, Greg Armstrong, Thomas W. Pendergrass, Peter D. Inskip, John Mulvihill, Frederick P. Li, Debra L. Friedman, Vilmarie Rodriguez, Melissa M. Hudson, Robert M. Weetman, Kirsten K. Ness, Lonnie K. Zeltzer, Neyssa Marina, Amanda Termuhlen, Douglas C. Dover, A. T. Meadows, Gregory H. Reaman, Smita Bhatia, Norman E. Breslow, S.M. Davies, Kevin C. Oeffinger, Roger J. Packer, John D. Potter, Ann C. Mertens, Jackie Casallis, Jill Ginsberg, Brian Greffe, John D. Boice, Kathy Ruccione, Joseph P. Neglia, Sarah S. Donaldson, Yutaka Yasui, Joanna L. Perkins, A. Kim Ritchey, Roger L. Berkow, Holcombe E. Grier, Joseph Philip Neglia, Mark T. Greenberg, Dennis Deapen, Raymond J. Hutchinson, Terry A. Vik, Wendy M. Leisenring, ZoAnn E. Dreyer, Frederick B. Ruymann, Louise C. Strong, Teresa J. Vietti, Leslie L. Robison, Arthur R. Ablin, Daniel A. Mulrooney, Michael P. Link, Daniel M. Green, Jean M. Tersak

Publikováno v: Cancer. 112:2071-2079

BACKGROUND Limited data exist on the comprehensive assessment of late medical and social effects experienced by survivors of childhood and young adult acute myeloid leukemia (AML). METHODS This analysis included 272 5-year AML survivors who participa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a969f277bf28b1c23d22c6f44eafcf
https://doi.org/10.1002/cncr.23405

Langerhans cell histiocytosis: An exploratory epidemiologic study of 177 cases

Autor: Anna T. Meadows, Anthony Smithson, Leslie L. Robison, Jonathan L. Finlay, Merlin Hamre, Jonathan D. Buckley, Mark E. Nesbit, J. Hedberg, Smita Bhatia

Publikováno v: Medical and Pediatric Oncology. 28:92-97

There is little information available regarding epidemiologic risk factors for Langerhans cell histiocytosis (LCH). An exploratory investigation was conducted using information obtained from parents of 177 cases of LCH diagnosed before 21 years of ag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62bd7f9a702dc4dc7a4dc7374c72f58f
https://doi.org/10.1002/(sici)1096-911x(199702)28:2<92::aid-mpo2>3.0.co

The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia

Autor: Jonathan D. Buckley, G. Denman Hammond, Denis R. Benjamin, Ashok K. Srivastava, W. Anthony Smithson, Irwin D. Bernstein, Beatrice C. Lampkin, Lorrie F. Odom, Robert J. Wells, William G. Woods, Stephen A. Feig, Frederick B. Ruymann, Tae H. Kim

Publikováno v: Cancer. 66:1106-1113

The Children's Cancer Study Group instituted a pilot study to investigate the use of high doses of cytosine arabinoside (AraC) in the intensification phase of treatment for acute nonlymphocytic leukemia (ANLL). Patients achieving remission and not el

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::addf4ef2a75d801e93b83c0e40bb6d0c
https://doi.org/10.1002/1097-0142(19900915)66:6<1106::aid-cncr2820660605>3.0.co

Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study

Autor: W. Anthony Smithson, John D. Potter, Mark E. Nesbit, Leslie L. Robison, Kathy Ruccione, Joseph P. Neglia, Ann C. Mertens, Yutaka Yasui

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(13)

PURPOSE: Survivors of childhood and adolescent cancer are at risk for long-term effects of disease and treatment. The Childhood Cancer Survivor Study assessed overall and cause-specific mortality in a retrospective cohort of 20,227 5-year survivors.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b07646f9105b183c3b17d15538c3b1
https://pubmed.ncbi.nlm.nih.gov/11432881

A Novel Thrombopoiesis-Stimulating Agent, AMG 531: Pharmacokinetics and Pharmacodynamics in FcRn Knock-Out and Wild Type Mice

Autor: Anthony Smithson, Ann Watson, Rosalin Arends, Yu-Nien Sun, Janet L. Nichol

Publikováno v: Blood. 106:3575-3575

AMG 531 is a novel platelet-stimulating peptibody that targets the thrombopoietin (TPO) receptor, resulting in an increased production of platelets. This molecule consists of an Mpl receptor binding domain of peptide and a carrier Fc domain. The purp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::37cd5afdb0460188355b937c3b4c2df4
https://doi.org/10.1182/blood.v106.11.3575.3575